Compounding Regulation That Will Impact Your Home and Specialty Infusion Therapy Business
There's no doubt about it, your home and specialty infusion therapy business will be affected by the FDA's regulatory approach to compounding pharmacies. Are you ready to be proactive instead of reactive to what's coming down the pike? Join NHIA's June 3rd Talk Infusion Member Forum to discuss new information on these key areas and to successfully prepare yourself and your team for the near future:
- Hear how the FDA's regulation of compounding pharmacies can affect your business and what critical areas are of concern;
- Comprehend the ramifications of the FDA's recently circulated draft MOU (Memorandum of Understanding) and who will be impacted;
- Explore the latest concerns with FDA inspections of home infusion pharmacies; and
- Listen to experts share the latest developments with the Medicare Home Infusion Site of Care Act.
Faculty: Russell Bodoff, NHIA President and CEO; Kendall Van Pool, NHIA Vice President of Legislative Affairs; Bill Noyes, NHIA Vice President of Health Information Policy; Alan Parver, Esq., NHIA Policy Advisor, Arnall Golden Gregory, LLP and Steve Jurich, NHIA Senior Vice President and COO.
As always, ALL Employees of NHIA Member Organizations, in good standing, are invited to participate in this valuable, complementary member service—make sure YOU and YOUR TEAM fully leverage this member benefit!